The initiation of coverage by UBS with a Neutral rating and a price target of $310 for Molina Healthcare (MOH) is likely to have a neutral impact on the stock price in the short term. The Neutral rating suggests that the analyst does not expect significant price movement in either direction. The price target of $310 may provide some guidance for investors, but the overall impact is expected to be neutral.